Preferences for Hereditary Breast and Ovarian Cancer Information among Mexican, Cuban and Puerto Rican Women at RiskQuinn G.P.a, b · McIntyre J.b · Vadaparampil S.T.a, b
aDepartment of Oncologic Sciences, University of South Florida College of Medicine, and bMoffitt Cancer Center, Health Outcomes and Behavior Program, Tampa, Fla., USA
Susan T. Vadaparampil, PhD, MPH
12902 Magnolia Drive
Tampa, FL 33612 (USA)
Tel. +1 813 745 1997, Fax +1 813 745 6525, E-Mail email@example.com
Do you have an account?
Background: Little is known about the preferences of at-risk Hispanic women to gain information on hereditary breast and ovarian cancer (HBOC). Aims: This study sought to qualitatively explore preferences for HBOC information among at-risk Mexican, Puerto Rican and Cuban women and to pilot a mock brochure aimed at Hispanic women. Methods: Hispanic women aged 18–65 years with a personal or family history of breast or ovarian cancer participated in a semistructured interview. Data were analyzed using a combination of open-coding and content analysis. Results: Fifty-three women participated in the study. For the majority of content areas, there were no major differences between the subethnicities. All women reported discussing cancer with a doctor after a family member had been diagnosed and discussing cancer within their families; however, the content of the discussion varied. Cuban and Puerto Rican women reported using the Internet routinely for health care information while Mexican women said they did not have access to computers and did not use them. All women liked the content and photos in the brochure but Mexican women thought the reading level was too high. Preferences for the spokesperson focused on the need for Spanish-speaking health care providers. Conclusions: While the data show some similarities, such as patterns of cancer discussion and appreciation of the mock brochure, there were differences between the groups on information preferences. In designing HBOC education information for Hispanic audiences, it is important to consider varied channels for dissemination and preferences for specific types of information across subethnicities.
© 2010 S. Karger AG, Basel
Projections of the resident population by age, sex, race, and Hispanic origin: 1999 to 2100. Washington, US Census Bureau, Population Projection Program, Population Division (NP-D1-A), 2000.
Ramirez R, de la Cruz P: The Hispanic population in the United States: March 2002, 2003. Washington, US Census Bureau, United States Department of Commerce, 2003.
Brodie M, Valdez J, Levin R, Suro R: National survey of Latinos: summary of findings. Menlo Park, Henry J. Kaiser Family Foundation and Pew Hispanic Center, 2002.
- Buki LP, Feigal BM, Carillo IY: Are all Latinas the same? Perceived breast cancer screening barriers and facilitative conditions. Psychol Women Q 2004;28:400–411.
Glanz K: Cancer in Women of Color Monograph. Bethesda, National Cancer Institute, 2003.
- Hunt LM, Comer B: Should ‘acculturation’ be a variable in health research? A critical review of research on US Hispanics. Soc Sci Med 2004;59:973–986.
- Zambrana RE, Fox SA, Gutierrez-Mohamed ML: Use of cancer screening practices by Hispanic women: analyses by subgroup. Prev Med 1999;29:466–477.
- John EM, et al: Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 2007;298:2869–2876.
- Weinick RM, et al: Hispanic healthcare disparities: challenging the myth of a monolithic Hispanic population. Med Care 2004;42:313–320.
- Lara M, et al: Acculturation and Latino health in the United States: a review of the literature and its sociopolitical context. Annu Rev Public Health 2005;26:367–397.
- Ramirez AG, et al: Hispanic women’s breast and cervical cancer knowledge, attitudes, and screening behaviors. Am J Health Promot 2000;14:292–300.
- Cheong PH: Health communication resources for uninsured and insured Hispanics. Health Commun 2007;21:153–163.
- Guest G, Bunce A, Johnson L: How many interviews are enough? Field Methods 2006;18:59–82.
Kvale S: Interviews: An Introduction to Qualitative Research Interviewing. London, Sage, 1996.
- Kinney AY, et al: Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation. Prev Med 2001;33:543–551.
- Lerman C, et al: Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 1995;57:385–392.
- Kinney AY, et al: Attitudes toward genetic testing in patients with colorectal cancer. Cancer Pract 2000;8:178–186.
- Ulrich CM, et al: Genetic testing for cancer risk: a population survey on attitudes and intention. Community Genet 1998;1:213–222.
Vadaparampil ST, Azzarello L, Pickard J, Jacobsen PB: Intention to obtain genetic testing for melanoma among first degree relatives of melanoma patients. Am J Health Educ 2007;38:148–155.
- Ashing-Giwa KT, et al: Understanding the breast cancer experience of women: a qualitative study of African American, Asian American, Latina and Caucasian cancer survivors. Psychooncology 2004;13:408–428.
- Mitchell JL: Cross-cultural issues in the disclosure of cancer. Cancer Pract 1998;6:153–160.
- Puschel K, et al: Factors related to cancer screening in Hispanics: a comparison of the perceptions of Hispanic community members, health care providers, and representatives of organizations that serve Hispanics. Health Educ Behav 2001;28:573–590.
- Talosig-Garcia M, Davis SW: Information-seeking behavior of minority breast cancer patients: an exploratory study. J Health Commun 2005;10(suppl 1):53–64.
- Suarez L, et al: Social networks and cancer screening in four US Hispanic groups. Am J Prev Med 2000;19:47–52.
- Armstrong K, et al: Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 2005;293:1729–1736.
- Prue CE, et al: But I’ve already had a healthy baby: folic acid formative research with Latina mothers. J Womens Health (Larchmt) 2008;17:1257–1269.
- Quinn GP, et al: Promoting pre-conceptional use of folic acid to Hispanic women: a social marketing approach. Matern Child Health J 2006;10:403–412.
- Quinn GP, et al: Evaluation of educational materials from a social marketing campaign to promote folic acid use among Hispanic women: Insight from Cuban and Puerto Rican ethnic subgroups. J Immigr Minor Health 2009;11:406–414.
- Lindau ST, et al: The association of health literacy with cervical cancer prevention knowledge and health behaviors in a multiethnic cohort of women. Am J Obstet Gynecol 2002;186:938–943.
- Lindau ST, et al: Improving rates of cervical cancer screening and Pap smear follow-up for low-income women with limited health literacy. Cancer Invest 2001;19:316–323.
- Scott TL, et al: Health literacy and preventive health care use among Medicare enrollees in a managed care organization. Med Care 2002;40:395–404.
- Sheppard VB, et al: If you build it, they will come: methods for recruiting Latinos into cancer research. J Gen Intern Med 2005;20:444–447.
- Katz JN: Patient preferences and health disparities. JAMA 2001;286:1506–1509.
- Larkey LK, et al: Hispanic cultural norms for health-seeking behaviors in the face of symptoms. Health Educ Behav 2001;28:65–80.
- Otero-Sabogal R, et al: Access and attitudinal factors related to breast and cervical cancer rescreening: why are Latinas still underscreened? Health Educ Behav 2003;30:337–359.
- Luquis RR, Villanueva Cruz IJ: Knowledge, attitudes, and perceptions about breast cancer and breast cancer screening among Hispanic women residing in South Central Pennsylvania. J Community Health 2006;31:25–42.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.